| Radiofrequency Ablation Growing In Popularity As A Treatment For ...
Millennium Research Group forecasts that radiofrequency ablation (RFA) procedures for cancer treatment will grow at almost 12% over the next five years in the US. According to Millennium Research Group's US Markets for Nonvascular Interventional Radiology Devices 2008 report, over 21,000 RFA procedures will be performed in 2007 on patients with liver, kidney, breast, lung, and metastatic bone cancers; by 2012, RFA procedures will reach over 36,000.
Physicians are opting for this surgery due to its minimally invasive nature and its ability to safely and precisely ablate small tumors. If the continued release of clinical evidence supports RFA treatment as a viable alternative to surgical resection, physician confidence in and the subsequent adoption of RFA devices take place.
"RFA can be used in cases where surgical resection poses too great of a risk to the patient," says Stephanie LaBelle, Analyst at MRG.
Cancer victim helps prescribe spiritual Rx for patients at local ...
Right before Christmas, a woman sat quietly in a sterile medical office in Riverside, Calif. as she listened to the results of recent tests. Her Kaiser doctor explained the options she hadto live or die. Lynn Koch, who was diagnosed with breast cancer Dec. 6, had the biopsy two days later and before she got dressed they asked when she wanted to schedule surgery. "It all went so fast," she said. "But I had no fear." Since then she has been cleared of cancer and has started a yearlong treatment of chemotherapy to keep the cancer from recurring. She credits a prescription she was given from a man in Tennessee with the results of her quick healing and "fear-free" existence, knowing many women die as a result of this disease every year.
Crystal Lake man indicted in fatal punch at bar
A Crystal Lake man has been indicted on first-degree murder and aggravated battery charges after an altercation outside a bar in September turned fatal, authorities said Thursday.
Bail was set at $750,000 for Dustin Goy, 30, of the 1000 block of Barlina Road at a hearing Wednesday in McHenry County Circuit Court, authorities said
Goy is accused of punching Anthony Carlsen, 45, in what witnesses said was an unprovoked attack Sept. 9 outside The Cottage at 6 E. Crystal Lake Ave., said Crystal Lake Deputy Police Chief Dennis Harris. Carlsen, of Crystal Lake, died of his injuries a week after the attack.
.
Top police officer warns that nuclear attack is inevitable
More than 300 experts from 70 countries were taking part in a high-level meeting organised by the UN International Atomic Energy Agency on the risks of nuclear terrorism. The police response to a CBRN incident when it happened would have a "profound effect on our communities which should not be underestimated", he said. The protective clothing that officers would have to wear would look "terrifying". As Dickinson made the point in his speech on Wednesday, one of his fellow police officers appeared dramatically on the stage dressed head to toe in a regulation black protection suit. With his face completely obscured by a gas mask, the officer then walked slowly through the delegates seated in the Edinburgh International Conference Centre. Decontamination after a radiation attack would be an "enormous cost", Dickinson contended.
Plucking the Pluckers
Is the target "liberals," on the grounds that the clientele of both chains are probably 95% Democratic? That's a pretty diffuse method of punishment--"Vote Republican or pay through the nose for sprouted wheat!" At other times, Gross makes it sound as if Bush is punishing some more specific enemy--yet the only victim he identifies is Daniel Gross of Slate, whose Connecticut town might be deprived of a Whole Foods outlet. This is paranoid. Maybe the Bushies are clean on this one. ... I mean, it's not as if Wild Oats' biggest shareholder is Bill Clinton's business partner and bachelor buddy who's also busy trying to buy up seemingly every available media property in advance of Hillary's 2008 run, right? ... Right? 10:37 P.M. Saturday, June 16, 2007 Bush Blows Up His Party: Glenn Reynolds argues the Administration is wrong to think it's up against only the "right wing blathersphere." ...
Give Green and Help Find a Cure This Holiday with Refillable Athena ...
In this season of giving, the refillable Athena� Sport Bottle is the perfect stocking stuffer that gives back in more ways than one. Available for purchase at www.athenawater.org, the reusable bottle provides a stylish and environmentally-friendly option for staying hydrated on the go, and 100% of the profits will be donated to crucial women's cancer research. Offered by Seattle-based non-profit Athena Partners�, the bottle bears a prominent pink ribbon and the words "GIVE 100%" to reflect the organization's approach to life and commitment to making a difference in the fight against cancer. The 24-ounce bottle is available in pink or blue and features elegant ergonomically curved sides, is dishwasher safe, and includes a drink-through lid to allow for a straw or to go without.
Mickey Kaus
I didn't know she was fighting cancer. She sent me an email only a couple of months ago cheerfully and sensibly disputing something I'd written arguing that Gov. Vilsack's candidacy would let Hillary skip the Iowa caucuses. (She wrote: "If Vilsack is running at the bottom of the Iowa Poll, as he was, he isn't a replay of Tom Harkin and doesn't give anyone a pass out of Iowa, methinks. ... And besides, Hillary being Hillary won't get a pass anywhere.") Orin was almost certainly right, as usual--where did Hillary spend last weekend, again? ... I only met Orin-Eilbeck a few times--mainly through the hospitality of her friend Mary Louise Oates, in whose house she was surrounded by Democratic friends. I'd heard she had a rep as a driven, badger-her-sources reporter, but everytime I met her she was funny and warm and sharp.
Micromet Receives Regulatory Approval to Conduct a Phase 2 Clinical ...
BETHESDA, Md., Oct. 18 /PRNewswire-FirstCall/ -- Micromet, Inc. (NASDAQ: MITI) , a biopharmaceutical company focusing on the development of novel, proprietary antibody-based products for the treatment of cancer, inflammatory and autoimmune diseases, announced today that the Paul-Ehrlich Institute has approved an Investigational Medicinal Product Dossier (IMPD) for the conduct of a phase 2 clinical trial testing MT103 in patients with acute lymphoblastic leukemia (ALL) in Germany. MT103, a BiTE(R) antibody targeting the CD19 antigen, which is expressed on most malignant B lymphoma cells, is also being evaluated in an ongoing phase 1 clinical trial in Europe in non- Hodgkin's lymphoma (NHL). Micromet and MedImmune, a subsidiary of AstraZeneca plc, are currently developing MT103 (also known as MEDI-538).
|
